ArticleActa Cardiologica Sinica2013
Increased Rosuvastatin Dose versus Concomitant Fenofibrate and Rosuvastatin Therapy to Achieve Lipid Goal in Patients with Diabetes or Atherosclerosis with Metabolic Syndrome.
Yeh-Peng Chen et al.PubMed ↗Full text ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it